← Open Payments lookup

MEENAKSHI PARMAR: Open Payments

NPI 1417170143 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$944 in 36 payments from 18 companies in 2025. Trend: 2023 $118 · 2024 $122 · 2025 $944

Food & beverage: $944
CompanyPaymentsAmount
Alkermes, Inc.2$143
E.R. Squibb & Sons, L.L.C.2$132
Otsuka America Pharmaceutical, Inc.5$109
TG Therapeutics, Inc.4$92
Tris Pharma Inc4$71
Collegium Pharmaceutical, Inc.3$59
ABBVIE INC.3$56
ACADIA Pharmaceuticals Inc2$52
Teva Pharmaceuticals USA, Inc.2$34
Neurocrine BioSciences, Inc.1$29

Products named: COBENFY, LYBALVI, BRIUMVI, REXULTI, Dyanavel XR, Jornay PM, VRAYLAR, NUPLAZID.

Industry payments across GA — which companies pay providers there.